These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35090432)

  • 1. A 7-gene signature predicts the prognosis of patients with bladder cancer.
    Tang F; Li Z; Lai Y; Lu Z; Lei H; He C; He Z
    BMC Urol; 2022 Jan; 22(1):8. PubMed ID: 35090432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.
    Li X; Fu S; Huang Y; Luan T; Wang H; Wang J
    BMC Cancer; 2021 Nov; 21(1):1267. PubMed ID: 34819038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of prognostic signature and nomogram for patients with breast cancer.
    Su J; Miao LF; Ye XH; Cui MS; He XF
    Medicine (Baltimore); 2019 Mar; 98(11):e14617. PubMed ID: 30882627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
    Zhao E; Bai X
    Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
    Hu Y; Fan S; Zhu Y; Xie X
    Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk model based on lncRNA-miRNA-mRNA gene signature for predicting prognosis of patients with bladder cancer.
    Zhao ZY; Cao Y; Wang HL; Liu LY
    Cancer Biomark; 2024; 39(4):277-287. PubMed ID: 38306023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
    Zhang C; Li Z; Hu J; Qi F; Li X; Luo J
    J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer.
    Zhao Y; Zhang Y; Dai C; Hong K; Guo Y
    Aging (Albany NY); 2022 Aug; 14(15):6169-6186. PubMed ID: 35939339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer.
    Jiang X; Xia Y; Meng H; Liu Y; Cui J; Huang H; Yin G; Shi B
    Front Oncol; 2021; 11():746029. PubMed ID: 34692528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
    Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
    Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram based on a gene signature for predicting the prognosis of patients with head and neck squamous cell carcinoma.
    Yang B; Fu L; Xu S; Xiao J; Li Z; Liu Y
    Int J Biol Markers; 2019 Sep; 34(3):309-317. PubMed ID: 31452437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sialyltransferases-related gene signature serves as a potential predictor of prognosis and therapeutic response for bladder cancer.
    Cao P; Chen M; Zhang T; Zheng Q; Liu M
    Eur J Med Res; 2023 Nov; 28(1):515. PubMed ID: 37968767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
    Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
    BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
    He Z; Deng T; Duan X; Zeng G
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer.
    Li Z; Zhao J; Huang X; Wang J
    Sci Rep; 2023 Mar; 13(1):4302. PubMed ID: 36922569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
    Li S; Liu X; Chen X
    BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.